Autopsy report · NCT03412253

Could Single-anastomosis Gastric Bypass Be a Curative Treatment for Type II Diabetes?

“financial causes, and the study will be continued within days.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 years 2 months after it had already started.
• Suspended: paused, and may or may not restart.
• 17 participants enrolled.

Vital statistics

Status

Suspended

Phase

Na

Sponsor

Ain Shams University

Sponsor type

University, hospital or other

Conditions

Metabolic Surgery

Interventions

Single-Anastomosis Gastric Bypass surgery (SAGB).

Participants

17

Trials that died the same way

• Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies
  “Study terminated due to slow accrual.” (71% match in meaning)
• Health Education for Physiotherapy in Soccer Players
  “The study was stopped by insufficient funds” (70% match in meaning)
• Assessment of Pulmonary Congestion During Cardiac Hemodynamic Stress Testing
  “Study was stopped due to funding and time constraints.” (70% match in meaning)
• Goserelin Acetate Study for Ovarian Function in Patients With Primary Breast Cancer
  “Study stopped due to low accrual.” (70% match in meaning)
• DNIC Using Deep Learning and Artificial Intelligence
  “The funding of the study is challenged. We might resume enrollment if new funds are found or will terminate the study.” (70% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.